MedTrace Logo

Barriers to the Implementation of Complete Insulin Order Sets

NCT00813280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-11-26

No results posted yet for this study

Summary

The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG \>300 mg/dl).

Conditions

Sponsors & Collaborators

  • International Diabetes Center at Park Nicollet

    collaborator OTHER

  • Park Nicollet Foundation

    collaborator OTHER

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Lisa Fish, MD · Park Nicollet Health Services Endocrinology

  • Robert M Cuddihy, MD · International Diabetes Center at Park Nicollet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-09-30
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00813280 on ClinicalTrials.gov